Ronald Tompkins
Ronald G. Tompkins, MD, ScD, was a leading trauma and burn specialist physician at the Massachusetts General Hospital, a leading ME/CFS researcher, and Chief Medical Officer at the Open Medicine Foundation until he passed away in 2022.[1][2]
Tompkins, along with Dr. Wenzhong Xiao, led the Harvard ME/CFS Collaborative Research Center, whose funding was provided by the Open Medicine Foundation.[3] After Dr Tompkins's sudden death in 2022 a tribute from the Open Medicine Foundation referred to him as a "dear friend to all" who was "driven by a fierce compassion for others" and had a "steadfast dedication to finding answers for millions suffering from Myalgic Encephalomyelitis / Chronic Fatigue Syndrome (ME/CFS) and related diseases.[2]
Contents
Positions[edit | edit source]
- Sumner M. Redstone Professor of Surgery, Harvard Medical School[4]
- Division Chief, Surgery, Science and Bioengineering, Division of Surgery, Massachusetts General Hospital[4]
- Founding Director, The Institute for Bioengineering and Biotechnology, a division in Surgery at Mass General[4]
- Founding Director, Center for Engineering in Medicine, Mass General[4]
- Director of the American Board of Surgery in 1994[4]
- Chief of Staff Emeritus at Shriners Hospitals for Children―Boston[4]
- Co-leader of the Harvard ME/CFS Collaborative Research Center[3]
Education[edit | edit source]
- BA, Chemistry, Tulane University, 1972
- MD, Medicine, Tulane University, 1976
- SM, Chemical Engineering, MIT, 1983
- ScD, Chemical Engineering, MIT, 1983
- Honorary M.A. from Harvard University[4]
Boards and committees[edit | edit source]
- Member of the Scientific Advisory Board of the Open Medicine Foundation[5]
- Member of the Working Group which offers their expertise and resources to the ME/CFS Collaborative Research Center at Stanford University[6]
Notable studies[edit | edit source]
Talks and interviews[edit | edit source]
- Sep 29, 2018, Second Annual Community Symposium on the Molecular Basis of ME/CFS 2018; talk title - ME/CFS Collaborative Research Center at Harvard - (Video)
- Jan 14 2019, Inflammation, Neural Function and ME/CFS Episode 103 of MECFS Alert
- May 31, 2019, Harvard Plans for Clinical Research into ME/CFS (Video), 14th Invest in ME Conference[7]
Online presence[edit | edit source]
See also[edit | edit source]
- Harvard ME/CFS Collaborative Research Center
- ME/CFS Collaborative Research Center at Stanford University
- Open Medicine Foundation
- Ronald Davis
Learn more[edit | edit source]
References[edit | edit source]
- ↑ "Open Medicine Foundation - Ronald G. Tompkins, MD, ScD". Open Medicine Foundation. Retrieved July 1, 2019.
- ↑ 2.02.1 Open Medicine Foundation (January 17, 2022). "Ronald G. Tompkins, MD, ScD". Facebook. Retrieved January 18, 2022.
- ↑ 3.03.1 "ME/CFS Collaborative Research Activities at MGH and the Harvard Affiliated Hospitals". Open Medicine Foundation. Retrieved July 1, 2019.
- ↑ 4.04.14.24.34.44.54.6 "Massachusetts General Hospital - Faculty Bios". Retrieved July 1, 2019.
- ↑ "Scientific Advisory Board". Open Medicine Foundation. Retrieved July 1, 2019.
- ↑ "OMF grants $1.2 million to ME/CFS Collaborative Research Center at Stanford". Open Medicine Foundation. Retrieved July 1, 2019.
- ↑ "Invest in ME Research - IIMEC14 14th Invest in ME Reseaerch International ME Conference 2019". Invest in ME Research. Retrieved February 26, 2020.
myalgic encephalomyelitis (M.E.) - A disease often marked by neurological symptoms, but fatigue is sometimes a symptom as well. Some diagnostic criteria distinguish it from chronic fatigue syndrome, while other diagnostic criteria consider it to be a synonym for chronic fatigue syndrome. A defining characteristic of ME is post-exertional malaise (PEM), or post-exertional neuroimmune exhaustion (PENE), which is a notable exacerbation of symptoms brought on by small exertions. PEM can last for days or weeks. Symptoms can include cognitive impairments, muscle pain (myalgia), trouble remaining upright (orthostatic intolerance), sleep abnormalities, and gastro-intestinal impairments, among others. An estimated 25% of those suffering from ME are housebound or bedbound. The World Health Organization (WHO) classifies ME as a neurological disease.
The information provided at this site is not intended to diagnose or treat any illness.
From MEpedia, a crowd-sourced encyclopedia of ME and CFS science and history.
